Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...
(RTTNews) - Shares of Recursion Pharmaceuticals, Inc. (RXRX) are trading down on Thursday morning after surging to a year-to-date high on yesterday after announcing a collaboration and $50 million ...
As shown in the following leadership transition slide: Despite the revenue challenges, Recursion emphasized its strong cash position and milestone achievements from partnerships. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results